TP53 and neoplasm: Therefore, it was hypothesized that p53-controlled apoptotic signaling plays an important role in the response of TGCTs to chemotherapeutic drugs, and the lack of p53 mutations explains at least in part the therapeutic response of this type of tumor to cisplatin.